The Discovery and Significance of a Human Copper-Binding Peptide The story of GHK-Cu begins in 1973, when Dr
Elecoglipron was evaluated at fixed doses of 5mg, 15mg and 25mg, and regimens of 50mg (reached following dose escalation every two weeks) and 75mg (reached following dose escalation either every two or four weeks)
This highlights the potency and risk of misuse of the compound
PMID: 32517842 Grativol AD, et al
MeAgain is especially useful if your real question is: "How do I know what happened this week?" not just "Did I feel a symptom?" Bottom line: MeAgain is built for people who want to know what actually happened this week, not just whether a symptom occurred
Lack of access to lab results and other clinical information prevented adjustment for variables such as BMD, BMI, and glycemic control (e.g., HbA1c)